Immunohistochemistry

NM Nanna Monjé
MD Mihnea P. Dragomir
BS Bruno V. Sinn
IH Inga Hoffmann
AM Anuar Makhmut
TS Tincy Simon
CK Catarina A. Kunze
JI Jana Ihlow
WS Wolfgang D. Schmitt
JP Jonathan Pohl
IP Iris Piwonski
SM Sofya Marchenko
CK Carlotta Keunecke
TC Teodor G. Calina
FT Francesca Tiso
HK Hagen Kulbe
CK Caroline Kreuzinger
DC Dan Cacsire Castillo-Tong
JS Jalid Sehouli
EB Elena I. Braicu
CD Carsten Denkert
SD Silvia Darb-Esfahani
KK Kirsten Kübler
DC David Capper
FC Fabian Coscia
MM Markus Morkel
DH David Horst
CS Christine Sers
ET Eliane T. Taube
request Request a Protocol
ask Ask a question
Favorite

Immunohistochemical staining was performed semi-automatically on TMAs using a DISCOVERY XT/ULTRA autostainer (Ventana Medical Systems, Inc., Tucson, Arizona, USA). The following antibodies were used at dilutions previously tested on normal tissue: AHRR (1:3000, Abcam, Ref. No ab108518), COL5A2 (1:100, Sigma-Aldrich, Ref. No SAB4500385), FABP4 (1:1500, Abcam, Ref. No. ab92501), HMGCS2 (1:200, Abcam, Ref. No. ab137043), ITGA5 (1:600, Abcam, Ref. No. ab112183), SFRP2 (1:25, Abcam, ab92667), WNT9B (1:500, Abcam, Ref. No. ab151220). Positive and negative control tissues for antibody establishment were selected based on the manufacturer’s instructions and the Human Protein Atlas [17] (Supplementary Table 3). Universal negative controls of all TMAs were generated by omitting the primary antibody. If samples showed positivity (H-score ≥ 20, Supplementary Table 4), the affected samples were revised and excluded from all analyses. The stained TMAs were digitalised using the Pannoramic Slide Scanner (3D Histech, Budapest, Hungary).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A